1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCenters of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) is sponsored by National Institutes of Health (NIH). The Institutional Development Award (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding, including New Mexico.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Centers of Biomedical Research Excellence | National Institute of General Medical Sciences The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical research centers of excellence in an area of strategic importance to the organization and in alignment with the mission and priorities of the NIH.
The Fall 2025 open session of National Advisory General Medical Sciences Council includes the COBRE concept clearance. The COBRE program has two tracks that provide grantees with the means to build biomedical research capacity. The COBRE D-E-S track (three phases, maximum 15 years of support) is targeted toward institutions without any existing research capacity in the proposed broad area of research.
The COBRE E-S track (two phases, maximum 10 years of support) is intended for institutions with an existing degree of research capacity amenable to expansion and growth in the proposed area of research.
The five-year phases of the COBRE program are as follows: COBRE-D ( D evelopment Phase): Supports a long-term institutional vision leading to the creation of a center in a broad area of biomedical research that is currently not supported at the applicant organization through the recruitment of early career faculty, establishment of research facilities, and enhancement of research administration.
Notice of Funding Opportunity: PAR-27-054 . COBRE-E ( E xpansion Phase): Expands research capacity by growing the institutional faculty base, research projects, and core facilities. Notice of Funding Opportunity: PAR-27-055 .
COBRE-S ( S ustainability Phase): Sustains the expanded research infrastructure by continuing to grow the faculty and consolidating research cores to maintain research excellence beyond COBRE support. Notice of Funding Opportunity: PAR-27-055 . Notice of Informational Webinar on the COBRE-D Program: NOT-GM-26-020 .
COBRE Post-Award Project Submission and Approval Guidelines COBRE Interactive Portfolio Dashboard FAQs About COBRE E/S PAR-27-055 COBRE RPPR Suggested Tables PAR-27-055: COBRE-E/S (Expansion and Sustainability Phases) Preapplication Webinar Video PAR-27-055: COBRE-E/S (Expansion and Sustainability Phases) Preapplication Webinar Slides IDeA Program Allowable Major Equipment for Alteration and Renovation Projects [PDF] This page last updated on
According to the current listing, eligibility includes: Eligibility is restricted to institutions in IDeA-eligible states (including New Mexico) that award doctoral degrees in health-related sciences or are independent biomedical research institutes/medical centers with ongo…. Confirm the full requirements in the official notice before applying.
Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New Mexico. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-054 and PAR-27-055 replace COBRE's Phase 1-2-3 model with two tracks: a 15-year Development-Expansion-Sustainability path and a 10-year Expansion-Sustainability path. At $1.5 million per year in direct costs across 23 states and Puerto Rico, with new research cores prohibited in the final phase and eligibility capped at three active awards per institution, the track you claim is the most consequential choice in the application.
Read articleNOT-OD-26-112 released a draft NIH Biosafety Policy for Research Involving Biohazards on August 19, 2026. It would replace the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, extend IBC jurisdiction from engineered molecules to wild-type agents, toxins and prions, impose 24-hour incident reporting, and make the Biosafety Officer a federally defined role. Here is what actually changes and how to respond before the October 19, 2026 deadline.
Read articleNIH released a draft policy on August 27, 2026 that would require every NIH-supported clinical study to offer participants a plain-language summary of results — clinical trials within one year of completion, all other clinical research by the end of the funding period. It covers observational and behavioral research that ClinicalTrials.gov never touched. Here is the scope, the four requirements nobody has budgeted for, and what to say before the October 26 deadline.
Read article